Evidence map›Paper›PMID 35223919›Full record

ArticleFrontiers in medicine2022

Proteomic Signatures of Antimicrobial Resistance in

Brooke L Deatherage Kaiser, Dawn N Birdsell, Janine R Hutchison, Johanna Thelaus, Sarah C Jenson, Voahangy Andrianaivoarimanana, Mona Byström, Kerstin Myrtennäs, Ryelan F McDonough, Roxanne D Nottingham and 6 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Phylogeography ofFrontiers in microbiology · 2023
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 3 countries.

Brooke L Deatherage KaiserPacific Northwest National Laboratory, Chemical and Biological Signatures Group, Richland, WA, United States.
Dawn N BirdsellPathogen and Microbiome Institute, Northern Arizona University, Flagstaff, AZ, United States.
Janine R HutchisonPacific Northwest National Laboratory, Chemical and Biological Signatures Group, Richland, WA, United States.
Johanna ThelausSwedish Defence Research Agency, Chemical, Biological, Radioactive, and Nuclear (CBRN) - Defence and Security, Umeå, Sweden.
Sarah C JensonPacific Northwest National Laboratory, Chemical and Biological Signatures Group, Richland, WA, United States.
Voahangy AndrianaivoarimananaPlague Unit, Central Laboratory for Plague, Institut Pasteur de Madagascar, Antananarivo, Madagascar.
Mona ByströmSwedish Defence Research Agency, Chemical, Biological, Radioactive, and Nuclear (CBRN) - Defence and Security, Umeå, Sweden.
Kerstin MyrtennäsSwedish Defence Research Agency, Chemical, Biological, Radioactive, and Nuclear (CBRN) - Defence and Security, Umeå, Sweden.
Ryelan F McDonoughPathogen and Microbiome Institute, Northern Arizona University, Flagstaff, AZ, United States.
Roxanne D NottinghamPathogen and Microbiome Institute, Northern Arizona University, Flagstaff, AZ, United States.
Jason W SahlPathogen and Microbiome Institute, Northern Arizona University, Flagstaff, AZ, United States.
Herbert P SchweizerPathogen and Microbiome Institute, Northern Arizona University, Flagstaff, AZ, United States.
Minoarisoa RajerisonPlague Unit, Central Laboratory for Plague, Institut Pasteur de Madagascar, Antananarivo, Madagascar.
Mats ForsmanSwedish Defence Research Agency, Chemical, Biological, Radioactive, and Nuclear (CBRN) - Defence and Security, Umeå, Sweden.
David S WunschelPacific Northwest National Laboratory, Chemical and Biological Signatures Group, Richland, WA, United States.
David M WagnerPathogen and Microbiome Institute, Northern Arizona University, Flagstaff, AZ, United States.
Northern Arizona University · USPacific Northwest National Laboratory · USSwedish Defence Research Agency · SEInstitut Pasteur de Madagascar · MG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial resistance (AMR) is a well-recognized, widespread, and growing issue of concern. With increasing incidence of AMR, the ability to respond quickly to infection with or exposure to an AMR pathogen is critical. Approaches that could accurately and more quickly identify whether a pathogen is AMR also are needed to more rapidly respond to existing and emerging biological threats. We examined proteins associated with paired AMR and antimicrobial susceptible (AMS) strains of

Indexed as

antimicrobial resistance (AMR)fatty acid biosynthesisFrancisella tularensisproteomicsYersinia pestis

Identifiers

PMID35223919
PMCPMC8866660
OpenAlexW4211240532

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.